The AiMS Study: Assessing the impact of Monoclonal gammopathy of undetermined significance (MGUS). A pilot study (2016)

First Author: Murphy Blain
Attributed to:  The Centre of Excellence for Public Health (NI) - Phase II (CoEfPHNI/II) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Type: Conference/Paper/Proceeding/Abstract

Volume: 25

Parent Publication: PSYCHO-ONCOLOGY

Issue: SP. S3

ISSN: 1057-9249